NeurologyOnline.net

Neurology Xagena

Search results for "Alpha-synuclein"

Researchers at Johns Hopkins' Institute for Cell Engineering ( ICE ) have discovered a protein that could be the best new target in the fight against Parkinson's disease since the brain-damaging condi ...


Researchers at the Northwestern University are developing a novel gene therapy aimed at selectively turning off one of the genes involved in the development of Parkinson' s disease. The gene therap ...


Researchers at Whitehead Institute, in collaboration with colleagues at several research centers, including the University of Missouri's School of Biological Sciences, have identified a key biological ...


A protein known to be a key player in the development of Parkinson's disease is able to enter and harm cells in the same way that viruses do. The protein is called alpha-synuclein. The study has sh ...


An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, according to researchers at the University of Alabama a ...


No available treatments slow or halt progression of multiple system atrophy, which is a rare, progressive, fatal neurological disorder. In a mouse model of multiple system atrophy, Rifampicin ( Rifadi ...


Many patients with Parkinson's disease develop mild cognitive impairment ( MCI ) or dementia. Identifying biomarkers for cognitive impairment could be instrumental in facilitating both early diagnosis ...